Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease

Noguchi, Constance Tom, Rodgers, Griffin P., Serjeant, Graham, Schechter, Alan N. · 1988 · New England Journal of Medicine

Abstract

THE advent of pharmacologic strategies for increasing γ-chain synthesis in patients with sickle cell disease and other hemoglobinopathies1 2 3 4 5 6 7 has made it important to ascertain the benefit that may be expected from various increases in fetal hemoglobin (hemoglobin F) levels. Although the increases in hemoglobin F levels resulting from the use of drugs such as azacytidine and hydroxyurea appear to be moderate (≤20 percent hemoglobin F), the potential toxicity of these drugs is relatively high. Fortunately, in the past few years, epidemiologic analyses of the severity of sickle cell disease and studies of the biophysics of intracellular polymerization have led to . . .

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm198801143180207

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 35 references

Research works printed but not linked: 3

  1. Pembrey, 1980, Am J Hum Genet, 32, 26
  2. Schechter AN, Noguchi CT, Rodgers GP. Sickle cell anemia. In: Stamatoyannopoulos G, Nienhuis AW, Leder P, Majerus P, eds. Molecular basis of blood diseases. Philadelphia: W.B. Saunders, 1987:179–218.
  3. Sumoza, 1986, Blood, 68, 67a

Cited by

See all 222

Metadata

Authors
Noguchi, C. T., Rodgers, G. P., Serjeant, G., & Schechter, A. N.
Venue
New England Journal of Medicine
Published
1988-01-14
Volume
318
Issue
2
Pages
96-99
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2005752061
Cited by
222
References
35
Citations by year
2025: 5 · 2024: 6 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 4 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 12 · 2015: 4 · 2014: 5 · 2013: 2 · 2012: 6
FWCI
1.98
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
Keywords
sickle cell disease, fetal hemoglobin, hydroxyurea, azacitidine, hemoglobinopathies, disease severity
MeSH terms
Anemia, Sickle Cell, Azacitidine, Fetal Hemoglobin, Humans, Hydroxyurea, Polymers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease. https://app.cochat.ai/papers/10.1056/nejm198801143180207
The paper
Noguchi, C. T., Rodgers, G. P., Serjeant, G., & Schechter, A. N. (1988). Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease. New England Journal of Medicine. https://doi.org/10.1056/nejm198801143180207

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.